Product Description
The global electrophysiology lab system market was valued at $269.5 million in 2025. This is expected to increase over the forecast period at a CAGR of 4.4% to reach $364.8 million in 2032.
The full report suite on the global market for electrophysiology (EP) lab system includes 3D mapping systems and electrophysiology (EP) recording systems.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Electrophysiology Lab System Market Trends
In 2025, atrial fibrillation (AF) remains a major and expanding global public health burden, with contemporary estimates indicating that approximately 52.55 million people were living with AF and atrial flutter worldwide in 2021, underscoring sustained multi-decade growth in the addressable population for rhythm diagnosis and intervention. Aging demographics and rising cardiometabolic risk continue to increase cardiac arrhythmia incidence, and a meaningful share of incremental electrophysiology (EP) activity is concentrated in AF ablation. As procedural volumes scale, demand is rising for EP diagnostics and enabling technologies, alongside high-throughput energy platforms such as cryoablation and the rapidly scaling pulsed field ablation (PFA) workflow.
Global Electrophysiology Lab System Market Share Insights
- Johnson & Johnson strengthened its global EP leadership in 2025 with continued innovation in its CARTO 3™ mapping platform, including Version 8 with CARTO ELEVATE™ and CARTOSOUND FAM™ Paired with its THERMOCOOL SMARTTOUCH™ SF and QDOT MICRO™ ablation catheters, the ecosystem delivers higher mapping accuracy and more efficient workflows for complex arrhythmia procedures.
- GE HealthCare was the second-leading global EP lab system competitor in 2025. This position is driven by the high demand for its CardioLab AltiX AI.i recording platform and Allia IGS imaging systems in established markets like North America and Europe. The suite is supported by the Prucka 3 digital amplifier, ComboLab recording system and the AI-driven Volta AF-Xplorer decision support tool. This global market share is bolstered by rapid infrastructure expansion in the Asia Pacific region where local investments in new EP labs complement the mature technological adoption seen in Western hospitals. This integrated portfolio reinforces the focus of GE HealthCare on high-resolution signal processing and AI-enhanced workflows in complex arrhythmia procedures.
- Abbott held the third-leading EP lab system competitor, driven by growing adoption of its EnSite X™ mapping platform and the Advisor™ HD Grid SE catheter, supported by the EP WorkMate™ recording system, Ampere™ RF generator and TactiCath™ SE ablation catheter. This integrated portfolio reinforces Abbott’s focus on efficient workflows and high-resolution mapping in complex arrhythmia procedures.
Global Electrophysiology Lab System Market Segmentation Summary
- 3D Mapping System Market
- Electrophysiology Recording System Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
